biologic

Genotropin

somatropin

Loss of exclusivityOctober 2008projected — 12-year biologic exclusivity estimate
CompanyPharmacia & Upjohn Company LLC

Drug detail

Brand nameGenotropin
Active ingredientsomatropin
Strength12MG
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalOctober 1996
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Genotropin patent cliff — loss of exclusivity October 2008 | CliffBio